Common Stock, Shares, Outstanding of Immix Biopharma, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Immix Biopharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Immix Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 33,035,515, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Immix Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 33,035,515 +5,554,940 +20% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 28,406,301 +977,104 +3.6% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 27,852,341 +1,455,921 +5.5% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 27,540,020 +7,617,664 +38% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 27,480,575 +7,871,847 +40% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 27,429,197 +11,167,379 +69% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 26,396,420 +12,447,598 +89% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 19,922,356 +6,030,234 +43% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 19,608,728 +5,681,661 +41% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 16,261,818 +2,351,700 +17% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 13,948,822 +90,133 +0.65% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 13,892,122 +663,433 +5% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 13,927,067 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 13,910,118 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 13,858,689 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 13,228,689 +9,853,689 +292% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q4 2020 3,375,000 31 Dec 2020 10-K 28 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.